Covid-19 Update to QAA No 11 Extension of monitoring intervals for medicines in primary care

27th Apr 2020

The RDTC has updated COVID-19 QAA No. 11 - Extension of monitoring intervals for medicines in primary care. Changes to this version include clarification of routine 6-monthly lithium level monitoring in stable (>12 months) low risk patients is in line with NICE CG 185- Bipolar disorder: assessment and management.